TCL Archive NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA September 23, 1983
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
